NPI: 1982666111 · HOUSTON, TX 77030 · Air Ambulance · NPI assigned 04/04/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 204 | $272K |
| 2019 | 395 | $346K |
| 2020 | 4,462 | $1.21M |
| 2021 | 52,928 | $9.41M |
| 2022 | 55,706 | $10.20M |
| 2023 | 56,512 | $12.20M |
| 2024 | 36,749 | $5.82M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 20,099 | 19,230 | $11.87M |
| A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | 2,935 | 2,766 | $10.58M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 18,444 | 17,926 | $2.99M |
| A0436 | Rotary wing air mileage, per statute mile | 2,929 | 2,764 | $2.98M |
| 95716 | 1,057 | 1,015 | $2.12M | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,624 | 4,324 | $2.00M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 318 | 312 | $982K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 529 | 522 | $784K |
| 95700 | 1,099 | 1,065 | $536K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 21,330 | 17,750 | $383K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,351 | 4,815 | $344K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 238 | 231 | $314K |
| 80053 | Comprehensive metabolic panel | 8,470 | 6,988 | $309K |
| 95782 | 156 | 152 | $213K | |
| A0434 | Specialty care transport (sct) | 203 | 189 | $210K |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 246 | 244 | $195K |
| A0425 | Ground mileage, per statute mile | 1,506 | 1,423 | $188K |
| 80048 | Basic metabolic panel (calcium, ionized) | 10,086 | 7,789 | $164K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 99 | 90 | $152K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 936 | 891 | $150K |
| 81001 | 8,270 | 7,685 | $132K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,938 | 2,786 | $131K |
| A0422 | Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation | 2,726 | 2,564 | $116K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 507 | 496 | $112K |
| 76770 | 472 | 470 | $111K | |
| 71045 | Radiologic examination, chest; single view | 3,609 | 3,388 | $109K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,656 | 1,557 | $81K |
| 86850 | 2,879 | 2,643 | $69K | |
| J3490 | Unclassified drugs | 2,626 | 1,638 | $63K |
| 71046 | Radiologic examination, chest; 2 views | 1,537 | 1,451 | $59K |
| 87400 | 1,508 | 737 | $56K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 136 | 131 | $54K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 457 | 442 | $48K |
| A0398 | Als routine disposable supplies | 732 | 689 | $44K |
| 72125 | Computed tomography, cervical spine; without contrast material | 781 | 747 | $40K |
| 36512 | 13 | 13 | $36K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 85 | 83 | $33K |
| 93975 | 178 | 168 | $33K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,730 | 1,551 | $32K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,147 | 1,022 | $30K |
| 80076 | 2,314 | 2,068 | $30K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 791 | 744 | $25K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 273 | 265 | $24K |
| 76801 | 249 | 233 | $22K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,482 | 1,157 | $21K |
| 82977 | 534 | 442 | $21K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 48 | 48 | $20K |
| 96361 | Intravenous infusion, hydration; each additional hour | 485 | 428 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,213 | 740 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 498 | 476 | $16K |
| 84484 | 2,540 | 1,930 | $16K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 66 | 64 | $15K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,520 | 1,438 | $14K |
| 85610 | 4,047 | 3,184 | $14K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 46 | 24 | $12K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 706 | 682 | $11K |
| 86900 | 2,949 | 2,730 | $11K | |
| 82570 | 471 | 361 | $11K | |
| 86901 | 2,947 | 2,725 | $11K | |
| 83735 | 3,114 | 2,190 | $11K | |
| 82803 | 916 | 829 | $9K | |
| 81025 | 1,214 | 1,145 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,347 | 1,229 | $9K |
| 83690 | 1,521 | 1,402 | $9K | |
| 84702 | 719 | 659 | $9K | |
| 83880 | 633 | 604 | $8K | |
| 80197 | 402 | 268 | $8K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,523 | 2,897 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 268 | 246 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 677 | 222 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 785 | 340 | $7K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,348 | 1,228 | $7K |
| 85730 | 2,311 | 2,098 | $7K | |
| 83605 | 1,435 | 1,182 | $7K | |
| 96376 | 428 | 282 | $6K | |
| 83020 | 135 | 79 | $6K | |
| 82077 | 661 | 630 | $5K | |
| 84156 | 405 | 322 | $5K | |
| 84703 | 578 | 554 | $5K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 37 | 36 | $5K |
| 84100 | 2,382 | 1,706 | $5K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 66 | 63 | $5K |
| 97162 | 101 | 98 | $4K | |
| 84450 | 388 | 325 | $4K | |
| 85576 | 412 | 390 | $4K | |
| 82728 | 263 | 257 | $4K | |
| 84075 | 396 | 328 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 53 | 52 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 68 | 65 | $3K |
| 87799 | 26 | 12 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 126 | 58 | $3K |
| 73562 | 127 | 121 | $3K | |
| 87807 | 93 | 92 | $3K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 67 | 57 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 763 | 632 | $3K |
| 82330 | 742 | 463 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 70 | 69 | $2K |
| 82247 | 397 | 330 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 37 | 25 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 28 | 28 | $2K |
| 85384 | 531 | 489 | $2K | |
| 85390 | 324 | 309 | $2K | |
| 87497 | 31 | 26 | $2K | |
| 84155 | 389 | 326 | $2K | |
| 86999 | 58 | 52 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,090 | 965 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 59 | 53 | $2K |
| 82375 | 35 | 21 | $2K | |
| 82550 | 493 | 454 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 13 | 12 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 55 | 51 | $2K |
| J2704 | Injection, propofol, 10 mg | 1,366 | 1,316 | $1K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 49 | 27 | $1K |
| 83615 | 574 | 428 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 426 | 413 | $1K |
| 70498 | 14 | 12 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 75 | 75 | $1K |
| 85347 | 560 | 519 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 71 | 69 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | 401 | 372 | $1K |
| 97166 | 13 | 12 | $998.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,135 | 1,021 | $983.70 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 12 | 12 | $978.62 |
| 73610 | 56 | 53 | $971.09 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,216 | 1,154 | $909.06 |
| 87186 | 251 | 227 | $896.54 | |
| 85660 | 27 | 26 | $850.20 | |
| 82947 | 1,082 | 702 | $828.30 | |
| 86703 | 17 | 16 | $806.01 | |
| 70360 | 14 | 13 | $723.60 | |
| 86769 | 16 | 12 | $699.27 | |
| J1644 | Injection, heparin sodium, per 1000 units | 364 | 274 | $685.92 |
| 87340 | 41 | 38 | $670.06 | |
| 82043 | 106 | 80 | $653.19 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,647 | 1,579 | $651.16 |
| 82040 | 372 | 315 | $643.44 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 710 | 643 | $629.42 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,524 | 2,224 | $608.16 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 26 | 26 | $540.26 |
| 86780 | 31 | 27 | $536.60 | |
| 80061 | Lipid panel | 117 | 113 | $503.33 |
| 71250 | 14 | 13 | $480.51 | |
| 73130 | 27 | 26 | $476.96 | |
| 83970 | 14 | 12 | $462.75 | |
| 80179 | 49 | 43 | $427.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 328 | 300 | $421.22 |
| 73630 | 27 | 27 | $417.73 | |
| 80143 | 49 | 43 | $410.96 | |
| 94760 | 18 | 12 | $350.53 | |
| 90715 | 12 | 12 | $325.60 | |
| 84145 | 36 | 36 | $304.96 | |
| 73030 | 13 | 13 | $297.82 | |
| 73502 | 15 | 14 | $286.24 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 723 | 701 | $267.42 |
| 87040 | 48 | 38 | $252.96 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 229 | 201 | $220.30 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 69 | 67 | $214.23 |
| 36000 | 14 | 12 | $208.46 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 209 | 182 | $190.37 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 77 | 72 | $182.51 |
| 86140 | 68 | 64 | $164.63 | |
| 82610 | 89 | 67 | $150.58 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 78 | 77 | $142.63 |
| 82248 | 72 | 68 | $80.13 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 155 | 149 | $56.63 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 65 | 62 | $50.39 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 13 | 12 | $35.58 |
| 85045 | 20 | 15 | $23.45 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 13 | 12 | $17.18 |
| 36415 | Collection of venous blood by venipuncture | 1,094 | 937 | $1.35 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 44 | 44 | $0.00 |